Takeda Pharmaceutical Co Ltd
TAK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001395064
In the last 90 days, Takeda Pharmaceutical Co Ltd insiders filed 0 open-market purchases and 19 sales; 379 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; no superinvestor holds it.
Other share classesTKPHF
Q4 2021 vs. Q3 2021
How the institutions holding Takeda Pharmaceutical Co Ltd changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 294 | 3 | 299 | +8 |
| Shares | 92.0M | 12.6K | 76.1M | −15.9M (−17.2%) |
| Value | $1.51B | $207.0K | $1.04B | −$465.7M (−30.9%) |
3 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (61)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q4 2021 but not at the end of Q3 2021.
Sold out (53)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (3)
Institutions that held Takeda Pharmaceutical Co Ltd at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| HighPoint Advisor Group LLC | 11,515 | $189.0K |
| Berman Capital Advisors, LLC | 934 | $15.0K |
| Wealth Quarterback LLC | 129 | $3.00K |